Last reviewed · How we verify

NCT05304143: Claustro-VIR

Efficacy of Immersive Entertainement Glasses in Magnetic Resonance Imaging (MRI)

Completed NA Last updated 25 November 2022
What this trial tests

NA trial testing Virtual Immersive Reality Glasses in Claustrophobia in 206 participants. Completed in 3 November 2022.

Timeline
1 January 2022
Primary endpoint
3 November 2022
3 November 2022

Quick facts

Lead sponsorHospital Mutua de Terrassa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment206
Start date1 January 2022
Primary completion3 November 2022
Estimated completion3 November 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Mutua de Terrassa

Who can join

Adults 18 to 90, any sex, with Claustrophobia or Magnetic Resonance Imaging (MRI). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Claustrophobia is the most common type of specific phobia, and in the context of performing an MRI, it leads to premature completion of the test or a sedation. According to some authors, 1,6% of the patients terminated the test prematurely due to claustrophobia, and, in addition, 3.8% underwent conscious sedation. These procedures increase the risk of complications, and the cost of care. The use of anxiolytics is an option to reduce anxiety, but these drugs carry the possibility of suffering adverse effects, and the fact that patients cannot drive home when the MRI is finished. For these reasons, it is especially relevant to determine which non-pharmacological interventions are most effective, and among them, the use of Immersive Entertainment Glasses is a low-interventionist option that can help to overcome fear of the test. Objective: To determine the effectiveness of Immersive Entertainment Glasses in the success of the performance of an MRI and in the reduction of anxiety levels, in patients who express having claustrophobia. Methodology: Design: Clinical trial with intervention and control group. Participants: patients who define themselves as claustrophobic and should have an MRI. The sample will be made up of 206 individuals, divided between an intervention group and a control group. expecting a 20% difference between the success of the test of the control and intervention group subjects. People who meet the inclusion criteria will be distributed into the control or intervention group. The intervention group will use the Immersive Entertainment Glasses to perform the MRI and the control group will have the support of the nurse through educational techniques. Expected results: the success rate in performing MRIs is expected to increase by 20%, thanks to the use of Immersive Entertainment Glasses. Expected duration: 12 months, or until obtaining the expected sample.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Claustrophobia in magnetic resonance imaging: A randomised controlled trial of immersive entertainment glasses.
    Diaz-Membrives M, Garrido-Ribas I, Caro-Benito C, Font-Cabrera C, et al · · 2026 · PMID 41485316 · DOI 10.1016/j.radi.2025.103318

Verify or expand the search:

Other recruiting trials for Claustrophobia

Currently open trials in the same condition.

Other Hospital Mutua de Terrassa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05304143.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing